| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 08/27/2009 | US20090215736 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid |
| 08/27/2009 | US20090215730 Antineoplastic compounds and pharmaceutical compositions thereof |
| 08/27/2009 | US20090215725 Substituted 4-aminocyclohexane derivatives |
| 08/27/2009 | US20090215624 Alkoxyalkyl Spirocyclic Tetramic Acids and Tetronic Acids |
| 08/27/2009 | US20090215148 bioconjugates of chemically reactive carbocyanine dyes that are intramolecularly crosslinked between the 1-position and the 3-position; use in analysis and separation of molecules and cells and for the detection and quantification of other materials |
| 08/27/2009 | US20090215025 Small peptidic and peptido-mimetic affinity ligands for factor viii and factor viii-like proteins |
| 08/27/2009 | US20090214436 Dichromic fluorescent compounds |
| 08/27/2009 | CA2716332A1 Compounds and compositions as modulators of gpr119 activity |
| 08/27/2009 | CA2707853A1 Novel diazeniumdiolate derivatives, method for the preparation thereof and pharmaceutical compositions containing the same |
| 08/26/2009 | EP1590338B1 Modulators of melanocortin receptor |
| 08/26/2009 | EP1485087B1 (+)-2- [1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione for use in treating psoriasis by oral administration |
| 08/26/2009 | EP1012187B1 Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response |
| 08/26/2009 | CN101516856A Heterocyclic bridged biphenyls and their use in oleds |
| 08/26/2009 | CN101516844A 4-heteroaryl-substituted 1-aminocyclohexane-1- and cyclohexene-1-derivatives having effects on the opiod receptor system |
| 08/26/2009 | CN101516834A Isoserine derivatives for use as coagulation factor ixa inhibitors |
| 08/26/2009 | CN101516366A Oxindole derivatives as anticancer agents |
| 08/26/2009 | CN101515632A Organic light-emitting element |
| 08/26/2009 | CN101514181A Novel method for preparing ramipril intermediate |
| 08/26/2009 | CN101514180A Perindopril tert-butylamine salt crystal I and method for preparing same |
| 08/26/2009 | CN101514179A Indolone hydrazine ethylidene carbonyl compound, method for preparing same and application thereof in medicine |
| 08/26/2009 | CN100532374C Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders, process for their preparation and pharmaceutical compositions containing same |
| 08/25/2009 | US7579483 Process for preparing 7-(acryloyl)indoles |
| 08/25/2009 | US7579469 For therapy of disease characterized by inflammatory, allergic, or proliferative processes |
| 08/25/2009 | US7579419 Superior in hole injecting property, making it unnecessary to add a strongly acidic dopant for enhancing hole injecting property; may be useful in flat panel display devices |
| 08/25/2009 | US7579411 Process for the controlled increase in the molecular weight of polyethylenes |
| 08/25/2009 | US7579365 For therapy of oncoses |
| 08/25/2009 | US7579347 Vanilloid receptor ligands and their use in treatments |
| 08/25/2009 | CA2269246C Substituted tricyclics |
| 08/20/2009 | WO2009103022A1 Derivatives of substituted fused ring cycloindoles and methods of their use |
| 08/20/2009 | WO2009102805A1 Indole compounds and methods of use thereof |
| 08/20/2009 | WO2009102778A1 Amorphous polymorph of bazedoxifene acetate |
| 08/20/2009 | WO2009102773A1 Methods of preparing polymorphic form a of bazedoxifene acetate |
| 08/20/2009 | WO2009102771A1 Methods of converting polymorphic form b of bazedoxifene acetate to polymorphic form a of bazedoxifene acetate |
| 08/20/2009 | WO2009102083A1 Novel clitocybin derivatives, preparation method thereof and composition containing the extract of clitocybe aurantiaca kctc 11143bp or the novel clitocybin derivatives for prevention of aging as an active ingredient |
| 08/20/2009 | WO2009074733A3 Addition salts of angiotensine-converting enzyme inhibitors with no donor acids, method for preparing same and pharmaceutical compositions containing same |
| 08/20/2009 | WO2009055721A3 5-lipoxygenase activating protein (flap) inhibitor |
| 08/20/2009 | US20090209760 Organometallic complexes as phosphorescent emitters in organic leds |
| 08/20/2009 | US20090209710 Method of Modifying a Macromolecular System |
| 08/20/2009 | US20090209611 Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them |
| 08/20/2009 | US20090209598 Resorcine Derivatives and Their Use as Pesticides |
| 08/20/2009 | US20090209532 Pharmaceutical compounds |
| 08/20/2009 | US20090208872 Sulphonium Salt Initiators |
| 08/20/2009 | US20090206731 Rigid Amines |
| 08/20/2009 | CA2715282A1 Indole compounds and methods of use thereof |
| 08/20/2009 | CA2714494A1 Methods of preparing polymorphic form a of bazedoxifene acetate |
| 08/19/2009 | EP2090309A1 Use of thiazole inhibitors of fatty acid oxidation of formula (I) for the treatment of Alzheimer's disease and other neurological conditions |
| 08/19/2009 | EP2089417A2 Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid |
| 08/19/2009 | EP2089360A1 Spiroindolinone derivatives |
| 08/19/2009 | EP2089019A2 Polymorphs of a hydroisoindoline tachykinin receptor antagonist |
| 08/19/2009 | EP1984335B1 Improved process for the preparation of stable nitroxyl radicals |
| 08/19/2009 | EP0774122B1 Merocyanine dye protein stains |
| 08/19/2009 | CN101508744A Carbazole oxime ester lightlike initiating agent |
| 08/19/2009 | CN101508702A Tetrahydroquinoline and indoline derivative phosphor nitrogen ligand, synthesis and uses thereof |
| 08/19/2009 | CN101508670A Compound for forming organic film, and organic light emitting device and flat panel display device including the same |
| 08/19/2009 | CN101508669A Green synthesis of indole compounds |
| 08/19/2009 | CN101508668A Novel C8 side-chain hydrogenated iso-indole ketone compounds, preparation method and application thereof |
| 08/19/2009 | CN101508649A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 08/19/2009 | CN100528879C S type 4-substituted hydroxy-pyranindolelidinyl compounds and its derivatives and production method |
| 08/19/2009 | CN100528863C Method for manufacture of sertindole |
| 08/19/2009 | CN100528838C Oxime ester photoinitiatros having combined structure |
| 08/19/2009 | CN100528821C Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative |
| 08/19/2009 | CN100528164C Statin therapy for enhancing cognitive maintenance |
| 08/18/2009 | US7576245 Using a fluorinated phenyl compound containing electrophilic and nucleophilic groups; increasing the fluorous nature of an organic compound; 4-(1H,1H,2H,2H-Perfluorodecyl)benzenesulfonamide; N-[4-(1H,1H,2H,2H-perfluorodecyl)benzyloxycarbonyloxy]succinimide |
| 08/18/2009 | US7576222 N-{[4-(but-2-ynyloxy)phenyl]sulfonyl}-1-(2-fluorobenzyl)-5-methoxy-2-methyltryptophan; for treatment of rheumatoid arthritis, juvenile rheumatoid arthritis, ulcerative colitis, or Crohn's disease |
| 08/18/2009 | US7576129 Carboxylic acid compounds |
| 08/18/2009 | US7576120 Azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them |
| 08/18/2009 | US7576118 Asymmetric hydrogenation process |
| 08/18/2009 | US7576082 rac-6-Chloro-3-(3-chloro-benzyl)-3-(1-methyl-1H-pyrazol-4-yl)-1,3-dihydro-indol-2-one; murine double minute (MDM2 ) oncogene inhibitor; feedback control loop of p53 mutant cells; inhibit the interaction between p53 and MDM2 proteins |
| 08/18/2009 | US7576079 Viral polymerase inhibitors |
| 08/18/2009 | US7576072 Heterocyclic inhibitors of MEK and methods of use thereof |
| 08/18/2009 | CA2429133C Novel imidazole derivatives, production method thereof and use thereof |
| 08/18/2009 | CA2412208C Use of 3-substituted oxindole derivatives as kcnq potassium channel modulators |
| 08/18/2009 | CA2362760C Camptothecin derivatives having antitumor activity |
| 08/18/2009 | CA2239282C Fused isoindolones as inhibitors of protein kinase c |
| 08/13/2009 | WO2009099954A1 Novel positive photosensitive resin compositions |
| 08/13/2009 | WO2009099133A1 Compound having carbazolyl group and use thereof |
| 08/13/2009 | WO2009099060A1 Aromatic amine derivative and organic electroluminescent device using the same |
| 08/13/2009 | WO2009098251A1 NOVEL CYCLOALKANONE β-SUBSTITUTED ALANINE DERIVATIVES |
| 08/13/2009 | WO2009097972A1 Sf5 derivatives as par1 inhibitors, production thereof, and use as medicaments |
| 08/13/2009 | WO2009051660A3 Compounds for activating tgf-beta signaling |
| 08/13/2009 | WO2009019534A3 Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid |
| 08/13/2009 | WO2009016583A3 Indole amides as perfuming ingredients |
| 08/13/2009 | US20090203910 Deprotection of N-BOC compounds |
| 08/13/2009 | US20090203761 Process for preparing (3-oxo-2,3-dihydro-1h-isoindol-1-yl) acetylguanidine derivatives |
| 08/13/2009 | US20090203758 angiotensin converting enzyme inhibitors, used for the treatment of congestive heart failure aand as hypotensive agents; dissolving perindopril and L-arginine in water, adding apolar and polar solvents, then filtering, washing and drying the crystals obtained |
| 08/13/2009 | US20090203665 Heterocyclic-substituted phenyl methanones |
| 08/13/2009 | US20090203652 Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases |
| 08/13/2009 | US20090202921 Optical recording composition and holographic recording medium |
| 08/13/2009 | US20090200933 Triarylamine compounds, compositions and uses therefor |
| 08/13/2009 | US20090200928 Compound for forming organic film, and organic light emitting device and flat panel display device including the same |
| 08/13/2009 | CA2714181A1 Ampk modulators |
| 08/12/2009 | EP2086999A1 Inhibitors for disrupting the interaction of ubiquitination related enzymes and uses thereof |
| 08/12/2009 | EP2086945A2 Novel process for the preparation of statins and their pharmaceutically acceptable salts thereof |
| 08/12/2009 | EP2086933A2 Novel indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
| 08/12/2009 | EP2086932A2 Substituted aryl-indole compounds and their kynurenine/kynuramine-like metabolites as therapeutic agents |
| 08/12/2009 | EP2086931A1 Novel process |
| 08/12/2009 | EP2086930A2 Polymorphs of n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propenamide |
| 08/12/2009 | EP1902023A4 Improved process for preparing insecticidal (disubstitutedpropenyl) phenylalkyl substituted heterocycles |
| 08/12/2009 | EP1885695B8 Indoline compounds |
| 08/12/2009 | EP1756096B1 Indolyl derivatives as liver-x-receptor modulators |